Keywords: Eli Lilly, USA, Innovation, Policy suggestions

Eli Lilly CEO addresses USA’s innovation crisis as part of American DNA and actions necessary to continue that legacy

Article | 10 June 2010

Print This

Speaking at the Detroit Economic Club yesterday, John Lechleiter, chairman, president and chief executive of US drug major of Eli ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in